<< Back
The following sessions are included in this product:
AA Rewind 2017: Complete Package
Member Price: $399.00
NOTE: The Academy will not issue any refunds or exchanges for products purchased online. Purchased online activities are removed from "My Education (Mē)" after their expiration date. Please review the entire product description prior to purchase.
Nonmember Price: $499.00
Resident Price:$199.00
Nonmember Resident Price: $299.00
Release Date: December 2017
Release Date: December 2017
CME Expiration Date: December 31, 2020
NOTE: The Academy will not issue any refunds or exchanges for products purchased online. Purchased online activities are removed from "My Education (Mē)" after their expiration date. Please review the entire product description prior to purchase.
Description
This product contains recorded sessions that took place during the Academy's Annual Assembly held in Denver, CO from October 12-15, 2017.
The following sessions are included in this product:
Cancer Rehabilitation
- The Physiatrist’s Role in Cancer Recovery: Helping Patients with Cancer-Distinct Impairments (select presentations from the pre-course)
- Innovations to Improve Cancer Rehabilitation Outcome Assessment, Promote Referrals and Build an Evidence Base: A Guide to Pragmatic Implementation
- Building a Clinical Cancer Rehab Program
Central Nervous System Rehabilitation
- Expanding Access and Improving Outcomes for Spasticity Management Based on New Published Data
- Using New Technology and Instruments to Assess Level of Care in Patients Preparing to Enter the Post Acute Care Setting
- Getting Ahead of TBI Pain Syndromes
- Case-Based Discussion: Assessment and Treatment of Agitation After Traumatic Brain Injury
- Advancing Concussion Management through Innovative Technology
- Too Sexsci! Sexual Intimacy & Fertility after SCI• Ultrasound as an Extension of EMG/NCV
- Normal and Abnormal Gait Analysis: What do we need to know as Physiatrists? Specific Clinical Applications for runners and patients with lower extremity amputation
- Thriving Through Transformation: Sharpening Your Differential and Therapeutic Updates in Neuromuscular Diseases
- Arriving at the Optimal Orthotic Prescription
Leadership
- Bold Leadership Strategies and Tools for Today's Health Care Environment (select presentations from the pre-course)
- Positioning Physiatry in the Care Continuum – Part 1
- Positioning Physiatry in the Care Continuum – Part 2
Musculoskeletal Medicine
- Bench to Bedside: Athletes and Active Individuals with Early Knee Osteoarthritis
- The Great Debate: What the Evidence Shows in Musculoskeletal and Sports Medicine
- Direct Skeletal Attachment of Prosthetic Limbs with Osseointegration: Past, Present, and Future Considerations
- So My Docs Say I Have a Concussion: Challenges of Evaluating and Treating Concussion / Mild Traumatic Brain Injury in the Adult Working Population
- Advanced Musculoskeletal Ultrasonography: Emerging Technologies Beyond Grayscale Ultrasound
- Exercise is Powerful Medicine: How Physiatry Can Lead the Way In Transforming The Health Of Our Nation
- The Functional Medicine Matrix and Practical Applications in Your Practice
- AMSSM Exchange Lecture: Doping with in Sports
Pediatric Rehabilitation & Developmental Disabilities
- Spinal Muscular Atrophy: An Update on the New Hope that has Arrived for SMA
Practice Preparedness
- White Coat Nation: Employing Modern Technology in Medicine
- Why Education Doesn’t Stop with Residency: Implications Of New Finances, Program Building, And Physician Burnout For The Younger Physiatrist Transforming Into An Attending Role
- Overcoming Physician Burnout
- Spine Quality Outcomes Database: Pilot Site Learnings from The AAPM&R/AANS Joint Spine Patient Registry Initiative
- The Turbulent Health Policy Environment: Its Impact on Post-Acute Care (PAC), Physician Payment and Disability Services
- MIPS: Preparing Your Practice for Reporting and Strategies to Improve Performance
- Telemedicine: Harnessing Technology to Transform the Practice of Physical Medicine and Rehabilitation
Resident and Early Career
- Making the Most of Your Transition: What to Do when You Become a New Attending
Spine and Pain
- Effects of CDC Guidelines for Opioid Management on Physiatric Practices in Different Regions of the Country: What's Next in Your Region?
- Don't Get Fooled: How To Identify Statistical Weakness in Clinical Pain Studies Part I; A Lecture Session In Collaboration with the Spine Intervention Society (SIS)
- Therapeutic Cannabis Programs State of the Art Review 2017: State/Federal Regulatory Issues, Patient Benefits/Controversies, and Medical-Legal Aspects for Clinicians/Patients
- Spine Papers 2017
Method of Study
Each session contains video presentations that were recorded during the Annual Assembly. Upon viewing the presentations, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the individual sessions.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 53.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
AAPM&R Medical Education Committee:
Steven R. Flanagan, MD, Chair: Disclosed no relevant financial relationships.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.
AAPM&R CME Committee:
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.
AAPM&R CME Committee:
Kerrie M. Reed, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.